Simulations Plus teams with Nvidia on BioNeMo agent toolkit for drug development platform Composer

NVIDIA Corporation
Simulations Plus, Inc.

NVIDIA Corporation

NVDA

0.00

Simulations Plus, Inc.

SLP

0.00
  • Simulations Plus will build the agentic layer of its Composer drug-development platform using NVIDIA’s BioNeMo Agent Toolkit.
  • Work extends a May 2026 collaboration on GPU-accelerated simulation, shifting the partnership toward agent-driven modeling workflows.
  • Initial focus includes literature-grounded reasoning with Nemotron Parse, aiming to keep outputs traceable to original sources.
  • Partners will also advance nvQSP, a CUDA-optimized ODE-solver effort designed to speed quantitative systems pharmacology simulations at scale.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simulations Plus Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606230915BIZWIRE_USPR_____20260623_BW040671) on June 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.